Chia‐Ni Lin

738 total citations
37 papers, 539 citations indexed

About

Chia‐Ni Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Chia‐Ni Lin has authored 37 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Nephrology. Recurrent topics in Chia‐Ni Lin's work include Porphyrin Metabolism and Disorders (5 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Chia‐Ni Lin is often cited by papers focused on Porphyrin Metabolism and Disorders (5 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Chia‐Ni Lin collaborates with scholars based in Taiwan, United States and China. Chia‐Ni Lin's co-authors include Hung‐Chou Kuo, Hsuan-Ting Huang, Yan Sun, Yu‐Ting Huang, Yur‐Ren Kuo, Daniel Chiu, Gwendolyn A. McMillin, Szu‐Tah Chen, Andrew Wilson and William L. Roberts and has published in prestigious journals such as PLoS ONE, Kidney International and International Journal of Environmental Research and Public Health.

In The Last Decade

Chia‐Ni Lin

36 papers receiving 530 citations

Peers

Countries citing papers authored by Chia‐Ni Lin

Since Specialization

Citations

This map shows the geographic impact of Chia‐Ni Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Ni Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Ni Lin more than expected).

Fields of papers citing papers by Chia‐Ni Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chia‐Ni Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Ni Lin. The network helps show where Chia‐Ni Lin may publish in the future.

Co-authorship network of co-authors of Chia‐Ni Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chia‐Ni Lin. A scholar is included among the top collaborators of Chia‐Ni Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chia‐Ni Lin. Chia‐Ni Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Baseline urinary ALA and PBG as criteria for starting pharmacologic prophylactic treatment in acute intermittent porphyria treated with givosiran 2024 ·Molecular Genetics and Metabolism Reports ·Hung‐Chou Kuo, Long‐Sun Ro, Chia‐Ni Lin, Chun‐Che Chu, Ming‐Feng Liao, Hong‐Shiu Chang	1
2	Xenogeneic platelet-rich plasma lotion for preventing acute radiation dermatitis in patients with breast cancer undergoing radiotherapy: An open-label, randomized controlled trial 2024 ·JPRAS Open ·(unknown), Guo‐Shiou Liao, (unknown), (unknown), (unknown), Yu–Fu Su, Wen‐Yu Chuang, Chia‐Ni Lin, Kuen‐Tze Lin, Chun‐Shu Lin	0
3	Identification of blood metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with type 2 diabetes mellitus 2023 ·Journal of the Peripheral Nervous System ·Kuo‐Hsuan Chang, Chiung‐Mei Chen, Chia‐Ni Lin, (unknown), Rong‐Kuo Lyu, Chun‐Che Chu, Long‐Sun Ro, Ming‐Feng Liao, Hong‐Shiu Chang, Yi‐Ching Weng, Jawl‐Shan Hwang, Hung‐Chou Kuo	3
4	Clinical impact of therapeutic drug monitoring for newer anti-seizure medications in patients with epilepsy: A real-world observation study 2023 ·Biomedical Journal ·Siew‐Na Lim, Tony Wu, (unknown), (unknown), (unknown), Hsiang‐Yao Hsieh, Chih‐Hong Lee, Wey‐Ran Lin, Chunjing Liu, (unknown), Chia‐Ni Lin	4
5	Association between serum carcinoembryonic antigen and cardiometabolic risks: Implication for cardiometabolic prevention 2023 ·Frontiers in Endocrinology ·Chia‐Hao Chang, Hsu‐Huei Weng, Yu‐Chih Lin, Chia‐Ni Lin, Tung‐Jung Huang, Mei‐Yen Chen	1
6	Identification of Metabolomics Biomarkers in Extracranial Carotid Artery Stenosis 2022 ·Cells ·Chia‐Ni Lin, (unknown), Kuo‐Lun Huang, Wen‐Cheng Huang, (unknown), Tsong‐Hai Lee	7
7	Quantitation of mycophenolic acid and metabolites by UPLC-MS/MS in renal transplant patients 2022 ·Journal of Food and Drug Analysis ·(unknown), Ya‐Ching Huang, (unknown), Chia‐Ni Lin	2
8	Profiling of Serum Metabolites of Acute Intermittent Porphyria and Asymptomatic HMBS Mutation Carriers 2021 ·Cells ·Chia‐Ni Lin, Ming‐Shi Shiao, Mei‐Ling Cheng, Chiung‐Mei Chen, Hung‐Chou Kuo	7
9	Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review 2021 ·Journal of Neurology ·Siew‐Na Lim, Tony Wu, (unknown), (unknown), (unknown), Wey‐Ran Lin, Chia‐Ni Lin	12
10	Kynurenine/Tryptophan Ratio Predicts Angiotensin Receptor Blocker Responsiveness in Patients with Diabetic Kidney Disease 2020 ·Diagnostics ·(unknown), Chia‐Ni Lin, Daniel Chiu, Szu‐Tah Chen	12
11	Mutual Interaction of Clinical Factors and Specific microRNAs to Predict Mild Cognitive Impairment in Patients Receiving Hemodialysis 2020 ·Cells ·Jin‐Bor Chen, Chiung‐Chih Chang, Lung‐Chih Li, Wen‐Chin Lee, Chia‐Ni Lin, Sung‐Chou Li, Sin‐Hua Moi, Cheng-Hong Yang	6
12	Serum indoxyl sulfate predicts adverse cardiovascular events in patients with chronic kidney disease 2019 ·Journal of the Formosan Medical Association ·Pei‐Chun Fan, Chih‐Hsiang Chang, Chia‐Ni Lin, Cheng‐Chia Lee, Yi‐Ting Chen, Pao‐Hsien Chu, (unknown), Yueh-An Lu, Chih‐Wei Yang, Yung‐Chang Chen	38
13	Glycerophospholipids pathways and chromosomal instability in gastric cancer: Global lipidomics analysis 2019 ·World Journal of Gastrointestinal Oncology ·(unknown), Ta‐Sen Yeh, (unknown), Ren‐Chin Wu, (unknown), Meng‐Han Chiang, (unknown), Chia‐Ni Lin, Mei‐Ling Cheng, Gigin Lin	15
14	Amino acids and wound healing in people with limb-threatening diabetic foot ulcers 2019 ·Journal of Diabetes and its Complications ·Shih‐Yuan Hung, (unknown), Jiun‐Ting Yeh, Kuan‐Hsing Chen, Chia‐Ni Lin, Hui‐Mei Yang, Cheng-Wei Lin, (unknown), Chung‐Huei Huang, Yu‐Yao Huang	17
15	Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria 2018 ·Clinica Chimica Acta ·Chia‐Ni Lin, (unknown), Long‐Sun Ro, Ming‐Feng Liao, (unknown), Hung‐Chou Kuo	6
16	Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS 2018 ·Journal of Food and Drug Analysis ·Chia‐Ni Lin, I‐Wen Wu, (unknown), (unknown), (unknown), (unknown)	50
17	Reduction in Hospital-Wide Clinical Laboratory Specimen Identification Errors following Process Interventions: A 10-Year Retrospective Observational Study 2016 ·PLoS ONE ·(unknown), Chia‐Ni Lin, Daniel Chiu, (unknown), (unknown), (unknown), Tsung‐Lan Chu, (unknown), Tsu‐Lan Wu	17
18	Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI 2016 ·PLoS ONE ·Chia‐Ni Lin, (unknown), Wen‐Chang Chen, Yuesheng Wang, Li‐Wen Lee	7
19	Pediatric reference intervals for serum copper and zinc 2011 ·Clinica Chimica Acta ·Chia‐Ni Lin, Andrew Wilson, (unknown), (unknown), William L. Roberts, Gwendolyn A. McMillin	53
20	Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries 2006 ·Kidney International ·Chia‐Ni Lin, (unknown), Yur‐Ren Kuo, Yu‐Ting Huang, Hsuan-Ting Huang, Yan Sun, (unknown)	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact